Spectrum Pharmaceuticals (SPPI)
Spectrum Pharmaceuticals Market Cap: 684.86M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SPPI Market Cap Rankings
| Overall | 55th percentile | 2075 of 4664 |
| Sector | 67th percentile | 173 of 527 in Healthcare |
| Industry | 78th percentile | 36 of 164 in Biotechnology |
SPPI Market Cap Range, Past 5 Years
| Minimum | 43.73M | Jun 2008 |
| Maximum | 839.91M | Dec 2011 |
| Average | 293.06M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these SPPI related companies
SPPI News
From those, I only hold $AMRN... lots of it, really. But I won't touch $SPPI unless I see $10.5 or lower.
about 2 hours ago by mitrado
about 2 hours ago by mitrado
$AMRN, $SPPI, $KERX Any concerns about Friday Jobs report? Holding-selling-buying? http://stks.co/43Ed
about 3 hours ago by JasonMilano8
about 3 hours ago by JasonMilano8
@Bleedblue Loool. Basic english u r not understanding @Tarek307-how is ur day. Made 5times money today $AMRN. Tomorrow play $SPPI
about 2 days ago by SamRocks
about 2 days ago by SamRocks
@JasonMilano8 I was waiting for a dip in $SPPI, I got 50 shares of $SDRL instead. Nice dividend, while I'll keep waiting for $SPPI to dip.
about 2 days ago by mitrado
about 2 days ago by mitrado
$AMRN will buy at $10.55, $KERX will buy at $1.66, $SPPI will buy at $10.75
about 2 days ago by JasonMilano8
about 2 days ago by JasonMilano8
$AMRN performs worst after a patent confirmation than $SPPI does, after starting a Phase 1 test!? Ridiculous.
about 2 days ago by mitrado
about 2 days ago by mitrado
$SPPI announced the initiation of patient enrollment in a Phase - 1 clinical trial evaluating the safety & tolerability of RenaZorb.
about 2 days ago by ANDISIK
about 2 days ago by ANDISIK
Should have sold more of my $AIS, Why ? Bought $SPPI on 5/23/12 at $10.76 & on 5/29/12 at 10:24 am. its $11.69, up 8.7%.
about 2 days ago by ANDISIK
about 2 days ago by ANDISIK
@mitrado I hear ya, I've been waiting for a dip in $SPPI as well.....
about 2 days ago by chesty1
about 2 days ago by chesty1
@chesty1 Yes, day traders were waiting to sell near $12. They got it, they dumped it. Why can't this happen in $SPPI or $SDRL? I need a dip.
about 2 days ago by mitrado
about 2 days ago by mitrado
Spectrum Pharmaceuticals Announces Enrollment of First Group of Patients in Phase 1 Clinical Trial of RenaZorb®
May 29, 7:00AM Business Wire
May 29, 7:00AM Business Wire
Markets are going to be pretty messed for a while. Even so, I got a few more $AMRN on this dip. I'm watching $SPPI too. Looks very solid.
about 5 days ago by mitrado
about 5 days ago by mitrado
$SPPI And the stock has around a 50% short ratio. Is there some massive insider leakage or just over-zealous shorting due to PIII failure?
about 6 days ago by Glopolon
about 6 days ago by Glopolon
$SPPI Earnings were great in Q1, and forward outlook is also positive for Fusilev, deal for $ALTH is closing soon, so Folotyn is on the way.
about 6 days ago by Glopolon
about 6 days ago by Glopolon
$SPPI I know you short on news of a failed trial, Apaz., but typically that works really well on a company without other sources of revenue.
about 6 days ago by Glopolon
about 6 days ago by Glopolon
@Glopolon I think I'll wait a bit more on $SPPI. Hope it doesn't run away from me like $HGSI did.
about 6 days ago by mitrado
about 6 days ago by mitrado
$SPPI So, um, yeah, 50% of the float is short, on a company with no debt and decent profits. Mind boggling stuff.
about 7 days ago by Glopolon
about 7 days ago by Glopolon
@ANDISIK Don't worry. In these markets, $SPPI will drop again. I'm still waiting for $10 - $10.5 to get in.
about 7 days ago by mitrado
about 7 days ago by mitrado
Only put 45 thousand into $SPPI yesterday. Wish I had doubled or tripled that amount.
about 7 days ago by ANDISIK
about 7 days ago by ANDISIK
RT @JasonMilano8 $KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.LOL to early out
about 7 days ago by dkcba007
about 7 days ago by dkcba007
@JasonMilano8, Where do see the $SPPI share price in 2-3 weeks going to ??
about 7 days ago by ANDISIK
about 7 days ago by ANDISIK
$KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.
about 7 days ago by JasonMilano8
about 7 days ago by JasonMilano8
@casualtrader, $AIS. You should check out $SPPI, great company. I actually got back in today. ·
about 8 days ago by ANDISIK
about 8 days ago by ANDISIK
Allos (ALTH) Sees Increased Volatility; FTC Requests More Info on Merger with Spectrum (SPPI)
May 10, 9:44AM Street Insider
May 10, 9:44AM Street Insider
Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 08, 7:00AM Business Wire
May 08, 7:00AM Business Wire
Spectrum Pharmaceuticals to Present at the Deutsche Bank 37th Annual Health Care Conference
May 01, 7:00AM Business Wire
May 01, 7:00AM Business Wire
Spectrum Pharmaceuticals Reports Record Revenues and Profits for First Quarter of 2012
Apr 26, 7:00AM Business Wire
Apr 26, 7:00AM Business Wire
Tang Capital Management Raises Stake in Spectrum Pharmaceuticals, Inc. (SPPI) to 7.72%
Apr 23, 9:26AM Street Insider
Apr 23, 9:26AM Street Insider
Spectrum Pharmaceuticals Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV®
Apr 23, 7:00AM Business Wire
Apr 23, 7:00AM Business Wire
Spectrum Pharmaceuticals Announces First Quarter 2012 Financial Results Teleconference and Webcast
Apr 17, 7:00AM Business Wire
Apr 17, 7:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPPI | 11.56 | -0.23 | -1.99% | 698.79M |
| SPP | 3.16 | -0.13 | -3.95% | 1.646B |
| SPNS | 3.90 | -0.08 | -2.01% | 154.75M |
| SPN | 21.63 | +0.00 | +0.00% | 3.409B |
| SPMD | 2.62 | +0.02 | +0.77% | 40.22M |
| SPLS | 13.24 | -0.13 | -0.97% | 9.251B |
| SPIR | 0.7502 | -0.04 | -5.04% | 6.762M |
| SPIL | 5.285 | +0.01 | +0.28% | 3.264B |
| SPH | 36.71 | -0.27 | -0.73% | 1.313B |
| SPG | 148.11 | +1.93 | +1.32% | 43.53B |